From April 1, 2022 to June 30, 2022, the company has repurchased 54,009 shares, representing 0.78% for KRW 829 million. With this, the company has completed the repurchase of 227,719 shares, representing 3.24% for KRW 3,718.7 million under the buyback announced on February 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,500 KRW | +1.89% | +3.37% | +20.32% |
1st Jan change | Capi. | |
---|---|---|
+20.32% | 66.97M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- A049960 Stock
- News Cell Biotech Co., Ltd.
- Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.